Pricing

Log inSign up

ADC Therapeutics

1 follower

‌

ADC Therapeutics is a clinical-stage oncology biotechnology company leading the development and commercialization of next-generation antibody drug conjugates (ADCs) with highly potent and targeted pyrrolobenzodiazepine (PBD) dimer technology.

Industries

Biotechnology

Headquarters

Lausanne, Switzerland

Employees

201-500

Links

Org chart

Ameet Mallik
CEO

Ameet Mallik

Collapse
Kimberly Pope
Chief People Officer
Patrick van Berkel
Chief Scientific Officer
Michael Mulkerrin
Retired
Peter Graham
Chief Legal Officer
Jose Carmona
Chief Financial Officer
Kristen Harrington-Smith
Chief Commercial Officer
Mohamed Zaki
Chief Medical Officer
Jada Baijnath
Director Of Strategic Planning And Chief Of Staff
JF
Jay Feingold
Chief Medical Officer And Senior Vice President
Stephen Dudek
Director, Global Strategy & Lifecycle Management
Jesse Stromeyer
Executive Director, Head Of Marketing
NM
Niall McConnell
Head, Business Information Systems
RM
Ruchi Mallya
Forecasting & Commercial Data Analytics
Jason Moss
Head, Chemical Development & Manufacturing

Board & advisors

Ron Squarer
Chairman
Peter Hug
Vice-Chairman & Lead Independent Director
Stephen Evans-Freke
Non-Executive Director
Viviane Monges
Non-Executive Director
Thomas Pfisterer
Non-Executive Director
Tyrell J. Rivers
Non-Executive Director
Victor Sandor
Non-Executive Director
Jean-Pierre Bizzari
Non-Executive Director
Bob Azelby
Non-Executive Director

Teams

+13

Leadership Team

16 members

+9

Clinical Operations and Development

12 members

AB
+8

Finance and Accounting

11 members

Offices

Similar companies

Roivant Sciences

56 followers

Lonza

37 followers

Beam

9 followers

Schrödinger

8 followers

ElevateBio

5 followers

Roche

284 followers

Alector

3 followers

Nurix

3 followers

BioAgilytix

2 followers

ImmunityBio

2 followers

Avid Bioservices

2 followers

Explore companies